Precision Wealth Strategies, LLC Harrow Health, Inc. Transaction History

Precision Wealth Strategies, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 14, 2022	SELL	$5.75 - $7.74 $288,408 - $388,222	-50,158 Closed	0 $0
Q1 2022 May 04, 2022	SELL	$6.77 - $8.66 $197,785 - $253,001	-29,215 Reduced 36.81%	50,158 $342,000
Q4 2021 Jan 19, 2022	SELL	$8.5 - $12.0 $16,456 - $23,232	-1,936 Reduced 2.38%	79,373 $686,000
Q3 2021 Nov 02, 2021	BUY	$6.99 - $10.6 $110,295 - $167,257	15,779 Added 24.08%	81,309 $739,000
Q2 2021 Jul 22, 2021	BUY	$6.68 - $11.07 $1,082 - $1,793	162 Added 0.25%	65,530 $609,000
Q1 2021 Apr 26, 2021	BUY	$6.26 - $11.03 $16,457 - $28,997	2,629 Added 4.19%	65,368 $441,000
Q4 2020 Apr 26, 2021	BUY	$4.76 - $6.93 $298,637 - $434,781	62,739 New	62,739 $430,000

177

21.4M

845K

717K

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $1.15B
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

Get notified when there are updates to the investment portfolio of Precision Wealth Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Precision Wealth Strategies, LLC with notifications on news.